Steven L Basta
CIK 1417397 · President and CEO · last filed 2026-02-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.90M
Companies
6
Total Filings
40
Lifetime Open-Market Net
-$81.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PHAT | President and CEO | 373,315 | $10.37 | $3.87M | $0 | 6 | 2026-02-12 |
| VYNE | Director | — | $0.65 | — | $0 | 6 | 2025-12-15 |
| VIVE | Director | 25 | $0.00 | $0 | $0 | 11 | 2023-01-05 |
| VYNE Therapeutics Inc. (MNLO) Delisted | Chief Executive Officer | 536,537 | — | — | $0 | 10 | 2020-08-05 |
| KALV | Director | 1,125 | $27.00 | $30.4K | $0 | 1 | 2016-11-22 |
| BIOFORM MEDICAL INC (BFRM) Delisted | Chief Executive Officer | 0 | — | — | -$81.7K | 5 | 2010-02-19 |
Recent Filings · Page 3 of 4
40 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-03-23 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-11 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | +7,108 | $0 | EDGAR |
| 2019-12-16 | VYNE Therapeutics Inc. (MNLO) Delisted | Mixed | +167,590 | -$359.5K | EDGAR |
| 2019-12-13 | VYNE Therapeutics Inc. (MNLO) Delisted | Mixed | +167,590 | -$359.5K | EDGAR |
| 2019-11-27 | VIVE | Grant (A) | — | $0 | EDGAR |
| 2019-08-07 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-07-31 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-31 | VIVE | Grant (A) | — | $0 | EDGAR |
| 2019-04-03 | VIVE | Grant (A) | +24,199 | $0 | EDGAR |
| 2019-01-16 | VIVE | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.